Detalhe da pesquisa
1.
Impact of the COVID-19 Pandemic on Cancer Clinical Trials.
Ann Surg Oncol
; 28(12): 7311-7316, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236550
2.
Rates of and Factors Associated With Patient Withdrawal of Consent in Cancer Clinical Trials.
JAMA Oncol
; 9(8): 1041-1047, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347469
3.
Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer.
Cancer
; 118(21): 5358-65, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22434489
4.
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).
JAMA Oncol
; 8(5): 717-728, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297944
5.
Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience.
Trials
; 23(1): 645, 2022 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945621
6.
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222.
Cancer Invest
; 29(4): 266-71, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21345074
7.
Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
AJR Am J Roentgenol
; 197(2): 334-40, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21785078
8.
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO).
Immunotherapy
; 13(9): 727-734, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878954
9.
Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
Ann Intern Med
; 149(7): 441-50, W81, 2008 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18838724
10.
Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer Trials-Reply.
JAMA Oncol
; 10(3): 411, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236585
11.
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
Lung Cancer
; 60(2): 200-7, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18045731
12.
Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).
J Thorac Oncol
; 12(4): 697-703, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28089762
13.
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.
J Clin Oncol
; 23(25): 5929-37, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16135464
14.
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial.
J Thorac Cardiovasc Surg
; 149(3): 718-25; discussion 725-6, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25500100
15.
A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1).
Int J Radiat Oncol Biol Phys
; 52(2): 371-81, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11872282
16.
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
Int J Radiat Oncol Biol Phys
; 59(4): 943-51, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15234027
17.
Patient perceptions of stool DNA testing for pan-digestive cancer screening: a survey questionnaire.
World J Gastroenterol
; 20(17): 4972-9, 2014 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24803808
18.
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
J Clin Oncol
; 32(23): 2456-62, 2014 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982457
19.
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trials.
Clin Cancer Res
; 17(20): 6592-9, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21880789
20.
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
J Thorac Cardiovasc Surg
; 142(3): 554-62, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21724195